Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Clinical trial NCT05916911 · UNKNOWN
Trial details
- NCT number
- NCT05916911
- Sponsor
- Catalysis SL
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-07
- Primary completion
- 2024-06-04
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.